Rendu Biotechnology shareholder CENTRAL CHIEF LIMITED intends to inquire about the transfer of 1.25% of the company's shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Rendu Biotechnology disclosed the shareholder inquiry transfer plan, with the participating shareholder being CENTRAL CHIEF LIMITED, intending to transfer a total of 500,000 shares, accounting for 1.25% of the company's total share capital
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments